Society for Heart Attack Prevention and Eradication
  • Don't rely on cholesterol.
    Don't rely on cholesterol. 77% of heart attack victims had normal cholesterol.
  • Preventive Screening Becomes Law
    Preventive Screening Becomes Law The bill passed by Texas lawmakers would require reimbursement of up to $200 for certain approved screening tests for men between ages 45 and 75, and women between ages 55 and 75, who are at intermediate risk of a heart attack according to their Framingham Risk Score.
  • Don't Rely on Appearances
    Don't Rely on Appearances Winston Churchill lived to 89, and was an obese, heavy smoker and drinker.
  • Don't Rely on Risk Factors
    Don't Rely on Risk Factors Jim Fixx, world famous marathoner, died of a massive heart attack at age 52

Society for Heart Attack Prevention and Eradication

***The SHAPE Accredited Centers of Excellence program is a scientifically validated and guideline-based approach to early detection of Coronary Artery Disease.***

 

Learn more about the program and how it has emerged as the next step for improving heart health worldwide.

 

View our SHAPE Videos:

 

 

About

The Society for Heart Attack Prevention & Eradication (SHAPE) is a tax-deductible 501(c)(3) nonprofit organization that promotes public and professional education for early detection of individuals with atherosclerotic plaques that are at risk of heart attacks and stroke but have no symptoms. These individuals who are unaware of their risk are often misclassified by traditional methods (measuring risk factors such as cholesterol and blood pressure). Sadly every year approximately 600,000 of these asymptomatic individuals in the US and millions worldwide lose their life to a sudden heart attack or stroke. SHAPE is committed to saving these lives by raising awareness of the need for screening to detect asymptomatic atherosclerosis.

Mission

SHAPE's mission is to eradicate heart attacks and stroke by championing new strategies for prevention while advancing the scientific quest for a cure such as vaccines for heart attack. Heart attacks and stroke can and should be eradicated in our lifetime.

 

 


 

 

SHAPE Applauds U.S Preventive Services Task Force for Seeking the Truth about Coronary Artery Calcium

 

Evidence is Clear that Preventive Screening Tests for Coronary Artery Calcium Can Prevent Heart Attacks

 

HOUSTON, June 24, 2015 – SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the mission of eradicating heart attacks, today submitted a letter to the U.S. Preventive Services Task Force (USPSTF) strongly supporting the use of coronary artery calcium to assess an individual’s risk of heart attack. The USPSTF is currently accepting public comment for its “Draft Research Plan for Cardiovascular Disease: Risk Assessment Using Nontraditional Risk Factors.” Coronary artery calcium is among the nontraditional risk factors being considered.

 

Traditional risk assessment methods that rely solely on the Framingham Risk Score have proven to be suboptimal, as evidenced by the fact that 525,000 Americans suffer a first heart attack annually, according to the Centers for Disease Control and Prevention. Had they been evaluated the day before their heart attack by the traditional risk assessment method (Framingham Risk Score which relies on age sex, cholesterol blood pressure, smoking, etc.) the majority would fall in the Low to Intermediate Risk categories. This is unacceptable. 

 

SHAPE advocates using non-invasive screening tests to determine an individual’s coronary artery calcium score. The approach is modeled after successful screening protocols for breast and colorectal cancers once women and men reach a certain age.

 

“By relying on traditional risk assessment, many high risk and “vulnerable patients” are left unaware or inadequately treated, and many low risk individuals are inappropriately targeted for treatment, which burdens our healthcare system,” stated the SHAPE letter. The letter was signed by the Chairwoman of the SHAPE Board of Directors, JoAnne Zawitoski, SHAPE Scientific Chairman, P.K. Shah, M.D. and the founder of SHAPE and Executive Chairman of the SHAPE Task Force, Morteza Naghavi, M.D. 

 

SHAPE urged the USPSTF to review the work of the SHAPE Task Force, which has explored the advantages and limitations of various traditional and nontraditional methods of assessing risk of heart attack. This work, stretching back more than a decade, has included 15 scientific symposia and over 50 scientific publications on the topic the USPSTF is now examining.

 

The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine that works to improve the health of all Americans by making evidence-based recommendations about clinical preventive services such as screenings, counseling services and preventive medications.

 

About SHAPE

 

Based in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization that promotes education and research related to prevention, detection, and treatment of heart attacks. SHAPE is committed to raising public awareness about revolutionary discoveries that are opening exciting avenues to prevent heart attacks. SHAPE's mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization's Web site at www.shapesociety.org

 

About SHAPE Task Force

The SHAPE Task Force, an international group of leading cardiovascular physicians and researchers, has created the SHAPE Guidelines, which educates physicians how to identify asymptomatic atherosclerosis (hidden plaques) and implement proper therapies to prevent a future heart attack. According to the SHAPE Guidelines, individuals with high risk atherosclerosis (high plaque score) should be treated even if their cholesterol level is within the so called “normal range.” Knowing one's plaque score can be a matter of life and death. Additional information is available by calling 1-877-SHAPE11. And additional information is available at http://www.shapesociety.org.

The SHAPE Task Force includes the following:

 

Morteza Naghavi, M.D. – Executive Chairman
PK Shah, M.D. – Chair of Scientific Board
Erling Falk, M.D., Ph.D. – Chief of Editorial Committee

 

SHAPE Task Force Members (alphabetic order): Arthur Agatston, M.D., Daniel S. Berman, M.D., Matthew J. Budoff, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Sergio Fazio, M.D., Ph.D., Steven B. Feinstein, M.D., Craig Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis Kakadiaris, Ph.D., Sanjay Kaul, M.D., M.P.H., Asher Kimchi. M.D., Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Z. Naqvi, M.D., Jagat Narula, M.D., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee Shaw, M.D., David Spence, M.D., H. Robert Superko, M.D., Henrik Sillesen, M.D., Ph.D., Pierre-Jean Touboul, M.D.

 

Distinguished SHAPE Task Force Advisor: Valentin Fuster, M.D., Ph.D.

Chair of SHAPE Board of Directors: JoAnne Zawitoski, J.D.

SHAPE Task Force Public Relations: Daniel Keeney

Executive Director of SHAPE Centers of Excellence: Jeff Fine, Ph.D.

SHAPE Board Executive Secretary: Brenda Garrett Superko, CVRN

 

 

SHAPE Task Force Applauds Recent Urgent Calls to Overhaul CVD Prevention Guidelines

 

THE HEART ATTACK ERADICATION SOCIETY URGES DOCTORS TO ADOPT PERSONALIZED RISK ASSESSMENT

 

 

HOUSTON, TEXAS, November 14, 2014 – Leading preventive cardiologists and academic cardiovascular specialists from the Society for Heart Attack Prevention and Eradication (SHAPE), a non-profit organization advocating for early detection of future heart attack victims, endorse and applaud Dr. Steven Nissen’s urgent call to improve upon the existing inaccurate guidelines for detection and prevention of cardiovascular disease.

 

“We are delighted to hear Dr. Nissen and other well established physicians in the cardiology community call for revising existing guidelines” said Dr. PK. Shah, Chairman of SHAPE Scientific Advisory Board. “As many of you know, we have raised flags repeatedly since 2005 when we announced the SHAPE Guidelines and are looking forward to the much needed overhaul”. 

After 10 years, as the field of cardiology anxiously awaited the... read more   (.pdf)

 

 


  

Infographic Shows The Differences Between The Diseases We Donate To, And The Diseases That Kill Us

 


Credit: IFL Science / CDC

 

 


 

 



 

Primary Prevention of Atherosclerotic Cardiovascular Disease:

Noninvasive Screening - Polypill Therapy - Vaccination

 

View Video Presentations and Slides


Saturday, November 16, 2013, From 2:00 PM to 4:00 PM
The Adolphus Hotel, 1321 Commerce Street, Dallas, TX 75202

 

AGENDA

 

2:00 PM

 

Welcome and Opening Remarks
Morteza Naghavi, M.D., Founder of SHAPE and Executive Chairman of the SHAPE Task Force

 

video

download slides

 

2:10 PM

 

Modulating Autoimmunity in Atherosclerosis Using a Vaccines
Kuang-Yuh Chyu, M.D., Ph.D., Associate Director, CICU, Cedars Sinai Heart Institute, Cedars-Sinai Medical Center, West Hollywood, CA

 

 

 video

download slides

 

2:30 PM

 

Update on Noninvasive Imaging of Atherosclerosis and Prophylactic Polypill Therapy in High Risk Population
Valentin Fuster, M.D., Ph.D., Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Medical Center; Professor, Richard Gorlin, MD and Heart Research Foundation, Mount Sinai School of Medicine, New York, NY

 

 

 video

download slides

 

2:50 PM

 

National Institutes of Health’s Initiatives on Primary Prevention of Atherosclerotic Cardiovascular Disease - Future Directions
Lawrence J. Fine, M.D., Branch Chief, Clinical Applications and Prevention Branch,Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), Bethesda, MD

 

 

 

 video

download slides

 

3:10 PM

 

Q&A with Speakers and Discussion Panel
Topic: Primary Prevention of CVD and the Affordable Care Act

 

 

 

video

 

DISCUSSION PANEL


Moderator:

 

Harvey S. Hecht, M.D.
Associate Director of Cardiovascular Imaging, Mount Sinai Medical Center, New York; Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York

 

 

 

 


Participants:

 

Daniel S. Berman, M.D.
Chief of Cardiac Imaging and Nuclear Cardiology; Medical Director of Artificial Intelligence in Medicine Program; Professor of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA

 

 

 

 

 

Jay N. Cohn, M.D.
Professor of Medicine, Director, Rasmussen Center for Cardiovascular Disease Prevention, University of Minnesota, Cardiology Division, Minneapolis, MN

 

 

 

 

 

Tasneem Naqvi, M.D.
Director Echocardiography; Senior Associate Consultant, Mayo Clinic, Scottsdale, AZ

 

 

 



Faculty:


Arthur Agatston, M.D., Dan Arking, Ph.D., Juan J. Badimon, Ph.D., Raymond D. Bahr, MD,
Daniel Berman, M.D., Roger Blumenthal, M.D. Matthew Budoff, M.D., Jay N. Cohn, M.D., Michael Davidson, M.D., James E. Ehrlich, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Zahi A. Fayad, Ph.D., Sergio Fazio, M.D., Ph.D., Steve Feinstein, M.D., Valentin Fuster, M.D., Ph.D., Craig J. Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis A. Kakadiaris, Ph.D. , Sanjay Kaul, M.D., M.P.H., Asher Kimchi, MD, Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Naqvi, M.D., Jagat Narula, M.D., Khurram Nasir, M.D., M.P.H., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., John A. Rumberger, Ph.D., M.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee J. Shaw, Ph.D., Henrik Sillesen, M.D., D.MSc., J. David Spence, M.D., H. Robert Superko, M.D., Allen Taylor, M.D., PJ Touboul, M.D.

 

 

 


 

 

Once again MESA confirms SHAPE

"These findings, combined with the results of our analysis, suggest that CAC may be useful in determining the potential benefit of both aspirin and statin therapy, thus increasing the use of CAC as a tool for improved clinical decision making," authors write. Heartwire."

This is what SHAPE Task Force recommended about 10yrs ago. Read more.

 

 

 


SHAPE Observes First "Texas Blood Pressure Day" Event by Urging Everyone to Check for High Blood Pressure Regularly

High blood pressure (hypertension) is a serious condition that, if untreated, can worsen over time, leading to coronary heart disease, heart failure, aneurysms, stroke and kidney failure.

HOUSTON, TX - August 26, 2013 - Approximately one in three adults in the United States has high blood pressure and more than 20% don't even know they have it. Known as the silent killer, there are often no symptoms until the heart, arteries, and other organs are already damaged. And because of the obesity epidemic, more and more children are developing high blood pressure at earlier and earlier ages.

In the United States, blood pressure readings of less than 120/80 are considered normal. Readings between 120/80 and 139/89 are considered pre-hypertension. Anything above this level is regarded as hypertension, a serious medical condition requiring a doctor's care.

That's why periodically checking your pressure is so important. In recent studies, researchers determined that consistent tracking your own and your family's blood pressure at home can help control hypertension. These days, this potentially life-saving practice has become easier as the cost of home blood pressure monitors has diminished and accuracy has been improved.

 

 Click here for full press release..


 

SHAPE Advisor, Dr. Valentin Fuster Named Editor Of The Journal Of The American College Of Cardiology

SHAPE applauds the American College of Cardiology's decision to appoint Dr. Fuster to be the next editor-in-chief of the JACC, its acclaimed peer-reviewed publication.

(PRWEB) August 21, 2013 - The Society for Heart Attack Prevention and Eradication (SHAPE) is pleased to congratulate Dr. Valentin Fuster, renowned cardiologist and scientific investigator, on being named the next editor-in-chief of the Journal of the American College of Cardiology (JACC). He will succeed the current editor, Anthony DeMaria, M.D., beginning in 2014.

With an interest in preventive cardiology and early identification of the vulnerable patient, Dr. Fuster has been SHAPE's distinguished scientific advisor since its founding and is a staunch supporter of SHAPE's call for improving CVD risk assessment and early detection of high risk (vulnerable) patients. He has also been a featured presenter at many of the organization's scientific symposia.

Click here to view one of Dr. Fuster's outstanding presentations at SHAPE Symposium:

http://www.vcasmo.com/video/mcj1628/7856

 

  Click here for full press release..


 


 

                                                                                                                                                                                         Facebook link ss

                                                                                                                                                                        

 

Find a SHAPE Provider

HomeMap

 

 

Educational Media

 

 

CERTIFIED PROFESSIONALS

Become a SHAPE Certified
Medical Professional

Read More +

CENTER OF EXCELLENCE

Become a SHAPE Certified
Center of Excellence

Read More +

CIMT TRAINING

Carotid Intima Media Thickness ultrasound training.

Read More +